EUVIMEDEUVIMED entdecken
Delphi-Studie

Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique

Abir Saraswat, Sunil Dogra, Manjunath Shenoy, Shyam Verma, Seetharam K, Sunil Ghate, Anil Ganjoo, Sanjeev Aurangabadkar, Anurag Tiwari, Shital Poojary, Arun Inamdar, Imran Majid und 6 weitere

Dermatology · 2024

DOI: 10.1159/000538080 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Dermatology, 2024. Verfasst von Abir Saraswat und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Indushree Skin Clinic, Lucknow, India. Hauptthemen laut MEDLINE: Itraconazole, Antifungal Agents, Delphi Technique, Tinea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Super-bioavailable itraconazole (SB ITZ) overcomes the limitations of conventional itraconazole (CITZ) such as interindividual variability and reduced bioavailability. It has been approved for systemic mycoses in Australia and Europe as 50 mg and the USA as 65 mg and in India as 50 mg, 65 mg, 100 mg, and 130 mg. However, data on the ideal dose and duration of SB ITZ treatment in managing dermatophytosis are insufficient. This consensus discusses the suitability, dosage, duration of treatment, and relevance of using SB ITZ in managing dermatophytosis in different clinical scenarios. Sixteen dermatologists (>15 years of experience in the field and ≥2 years clinical experience with SB ITZ), formed the expert panel. A modified Delphi technique was employed, and a consensus was reached if the concordance in response was >75%. A total of 26 consensus statements were developed. The preferred dose of SB ITZ is 130 mg once daily and if not tolerated, 65 mg twice daily. The preferred duration for treating naïve dermatophytosis is 4–6 weeks and that for recalcitrant dermatophytosis is 6–8 weeks. Moreover, cure rates for dermatophytosis are a little better with SB ITZ than with CITZ with a similar safety profile as of CITZ. Better patient compliance and efficacy are associated with SB ITZ than with CITZ, even in patients with comorbidities and special needs such as patients with diabetes, extensive lesions, corticosteroid abuse, adolescents, and those on multiple drugs. Expert clinicians reported that the overall clinical experience with SB ITZ was better than that with CITZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ItraconazoleAntifungal AgentsDelphi TechniqueTineaConsensusHumansIndiaDermatologists

Stichwörter der Autor:innen

AdolescentConsensus statementDermatophytosisEfficacyItraconazoleOnychomycosisSafetySuper-bioavailable itraconazole

Substanzen

ItraconazoleAntifungal Agents

Autor:innen und Institutionen

  • Department of Dermatology, Indushree Skin Clinic, Lucknow, India.
  • Department of Dermatology, Venereology and Leprology Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Dermatology, Yenepoya Medical College, Mangalore, India.
  • Department of Dermatology, Nirvan Skin Clinic, Vadodara, India.
  • Department of Dermatology, GSL Medical College, Rajamundry, India.
  • Department of Dermatology, Dr Ghate's Skin, Hair and LASER Centre, Mumbai, India.

Zitieren

APA

Saraswat, A., Dogra, S., Shenoy, M., Verma, S., K, S., Ghate, S., Ganjoo, A., Aurangabadkar, S., Tiwari, A., Poojary, S., Inamdar, A., Majid, I., Girdhar, M., Shah, B., Varma, S., Ramamoorthy, R., Dhoot, D., & Barkate, H. (2024). Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique. Dermatology. https://doi.org/10.1159/000538080

Vancouver

Saraswat A, Dogra S, Shenoy M, Verma S, K S, Ghate S, et al. Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique. Dermatology. 2024. doi:10.1159/000538080

BibTeX
@article{Saraswat2024,
  author = {Saraswat, Abir and Dogra, Sunil and Shenoy, Manjunath and Verma, Shyam and K, Seetharam and Ghate, Sunil and Ganjoo, Anil and Aurangabadkar, Sanjeev and Tiwari, Anurag and Poojary, Shital and Inamdar, Arun and Majid, Imran and Girdhar, Mukesh and Shah, Bela and Varma, Sachin and Ramamoorthy, Ramkumar and Dhoot, Dhiraj and Barkate, Hanmant},
  title = {Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique},
  journal = {Dermatology},
  year = {2024},
  doi = {10.1159/000538080}
}
Kostenlos starten →